Market Overview

Pluristem Therapeutics, Inc. (NASDAQ: PSTI)

4.28 -0.07 (-1.61%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/31/18B. Riley FBRInitiates Coverage OnBuy4.5
10/06/17Seaport GlobalInitiates Coverage OnBuy5.0
6/19/17Maxim GroupUpgradesBuy
7/19/16H.C. WainwrightAssumesBuy3.5
9/15/14JefferiesMaintainsHold3.0
9/16/13Maxim GroupUpgradesBuy
6/05/13JefferiesMaintainsHold3.0
6/04/13Maxim GroupDowngradesHold
5/31/13McNicoll Lewis VlakInitiates Coverage onBuy4.5
3/19/13JefferiesInitiates Coverage onHold3.5

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter